Institutional Ownership
Biomarin Pharmaceutical Inc
CUSIP 09061G101COMBMRNQ1 2026
Institutional Holders
542
13F filers
Shares Held
165.02M
Aggregate institutional
Institutional Value
$9.07B
Q1 2026
Net New Holders
+6
74 new · 68 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions74
Increased211
Decreased160
Sold out68
Institutional Holders
542 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 19.82M | $1.12B | +683.2K | Added |
| 2 | Dodge & Cox | 14.56M | $822.59M | −10.6K | Reduced |
| 3 | Primecap Management Co/Ca/ | 14.19M | $801.82M | −355.3K | Reduced |
| 4 | Aqr Capital Management LLC | 7.68M | $429.35M | +989.6K | Added |
| 5 | State Street Corp | 7.30M | $412.10M | −228.1K | Reduced |
| 6 | Viking Global Investors LP | 7.06M | $398.94M | +1.03M | Added |
| 7 | Citadel Advisors LLC | 4.51M | $254.92M | +3.15M | Added |
| 8 | Geode Capital Management, LLC | 3.82M | $215.81M | +145.4K | Added |
| 9 | Dimensional Fund Advisors LP | 3.80M | $214.80M | +481.2K | Added |
| 10 | Vestal Point Capital, LP | 3.58M | $201.95M | +575.0K | Added |
532 more institutional holders on Premium
See every fund holding Biomarin Pharmaceutical Inc, with full quarter-over-quarter share changes.
Unlock all holders